By Connor Hart
Shares of Axon Enterprise climbed after the company more than doubled its profit and logged higher revenue in the fourth quarter.
The Taser maker additionally guided for better-than-expected sales in 2025.
Shares rose 13%, to $562, in after-hours trading Tuesday. Despite having gained 83% in the past year, the stock has lost roughly one-fifth of its value in the past three months.
The Scottsdale, Ariz., company posted net income of $135.2 million, or $1.67 a share, for its three months ended Dec. 31, compared with $57.1 million, or 75 cents a share, a year earlier.
Adjusted per-share earnings of $2.08 topped the $1.40 that analysts surveyed by FactSet expected.
Revenue increased to $575.1 million from $544.3 million and came in ahead of the $566 million that analysts modeled.
Taser revenue increased 37%, to $221 million, boosted by continued scaling of the company's Taser 10, as well as the growing adoption of the company's virtual-reality training solutions, it said. Sensors sales of $124 million were up 18% from last year.
The company said momentum is strong heading into the new year.
Axon guided for 2025 revenue of $2.55 billion to $2.65 billion, the midpoint of which is above the $2.56 billion that analysts polled by FactSet expect. It forecast adjusted earnings before interest, taxes, depreciation and amortization of $640 million to $670 million, the midpoint of which is also above the $650.5 million that analysts modeled.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
February 25, 2025 18:29 ET (23:29 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.